Word: stanleys
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Squibb are entering a period of declining revenue growth as patents on their major drugs expire, Novartis is poised for several years of steady double-digit expansion. This year its shares in the U.S. are up about 10%--the best performance among major drug companies--even as the Morgan Stanley Capital USA Health Care Index, a basket of big drug stocks, has fallen about 25%. Novartis is the 17th most valuable company in the world, up from 27th last year...
...expansion was partly in preparation for the launch of a potential blockbuster drug called Zelnorm, aimed at irritable bowel syndrome, for which there are few treatments. But the FDA, expressing concern about Zelnorm's side effects, rejected the application, asking for more data. In the short term, says Morgan Stanley analyst Duncan Moore, Novartis' prospects for robust growth depend heavily on the FDA's reversing its ruling on Zelnorm and approving an anti-inflammatory drug named Prexige, which Novartis plans to submit to the agency toward the end of this year...
...money controls the project to be accomplished. Chen connects the contract he just signed last week for Morgan Stanley’s real estate division with no feeling of duty but to his eventual dream to make buildings. “I see my two years at Morgan Stanley as a training ground for me to understand all the financial aspects of real estate so I can go and build my beautiful buildings. I don’t feel like I’m selling out.” As far as Mr. Gates’s challenge to give...
...former Merrill Lynch CEO E. Stanley O’Neal, the fall from financial power was fast. And while colleagues have blamed his go-it-alone approach, friends from his days at Harvard Business School remember a different Stan...
...Throw in the fact that disappointed investors will likely migrate to those funds that did well during the recent bout of volatility and you have a shakeout scenario. Huw Van Steenis, an asset-management analyst with Morgan Stanley, told a forum of European hedge-fund managers in October that a "super-league" of funds is slowly taking control of the industry. In 2006, 67% of all assets under management were controlled by this élite group of the top 100 funds, compared with 49% in 2003. "We think there's going to be a Darwinian process, a sorting...